J&J Urges Pa. Appeals Court To Undo $2.5M Risperdal Verdict
By Matt Fair ( August 8, 2018, 5:56 PM EDT) -- A Johnson & Johnson unit pushed a Pennsylvania appeals court on Wednesday to jettison a $2.5 million verdict on grounds that a trial judge improperly barred it from using a scientific article to challenge an expert's opinion that the antipsychotic drug Risperdal caused an adolescent boy to grow breasts....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.